Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.
about
The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancerRecent advances in studies on estrogen biosynthesisSolving the puzzle of hormone-dependent breast cancerClinical use of aromatase inhibitors: current data and future perspectives.The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuumPlasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancerThe influence of CGS 16949A on peripheral aromatisation in breast cancer patients.Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer.Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.The discovery and mechanism of action of letrozole.Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies.Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancerAminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancerSuppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer.The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide.Treatment of breast cancer with aromatase inhibitors--current status and future prospectsThe Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer.Aromatase inhibition 2013: clinical state of the art and questions that remain to be solvedPreservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women.Additive endocrine therapy for advanced breast cancer - back to the future.Letrozole.Exemestane in postmenopausal women with early or advanced breast cancer: a review.Biochemical and molecular aspects of aromatase.Aromatase inhibitors: introduction and perspective.New endocrine drugs for treatment of advanced breast cancer.Anticancer steroids: linking natural and semi-synthetic compounds.Comprehensive and Automated Linear Interaction Energy Based Binding-Affinity Prediction for Multifarious Cytochrome P450 Aromatase InhibitorsEndocrine therapy adherence: a cross-sectional study of factors affecting adherence and discontinuation of therapy.Aromatase inhibition for breast cancer treatment.Endocrine treatment of advanced breast cancer.
P2860
Q24683853-12EDBB0D-6D19-441E-ACD9-DC0E90E921EDQ28325249-A58545CD-6236-4FE7-9E19-AAC2DF3D9834Q33339120-2A18A2D3-833C-4E03-85CE-9DD9D53677F9Q33730581-901DE73F-3577-48A6-9DB4-F3B139775E3DQ34592879-8D66E03F-6613-4E3F-9BF1-2346083EF141Q35977200-B2416865-8FDC-443C-BFC9-A790AF2F189CQ35979241-35BC4AA5-3F8B-46CE-8A9C-D8B3BE89069CQ35982031-C6CD3432-4DC4-478F-8E1D-CC1B73FAA53DQ35984346-815C4A89-8B02-4EDF-9004-D54B0A63F941Q35991573-84CCF9B6-DFAA-42BC-AF91-0F562EC208C3Q35992084-7882172E-CFB4-4331-B734-DC476C116F36Q35992412-4BE6EC62-53BB-45DF-8BB9-D262C38CB60CQ35992446-A3000ABB-B9AB-432F-B3AB-BFC189768BC0Q35993244-2DE030A8-1DCD-4777-BCC1-AC45FFE05AAAQ36026408-2433F552-E8F5-4D40-97E8-C644DD42B097Q36027859-8F729037-7D5E-4930-9F35-B4A639B63EF8Q36047775-F0BF81E6-14CC-4F0A-8227-2C3428D8A57BQ36048153-8A2B4BE9-DF8D-4600-9015-F4FC21195FACQ36048194-2C44A498-1232-41CC-AC5C-3FB0753B0999Q36135060-FFD7C357-84FB-42CB-A302-35C4BCEEB5E8Q36138879-3E11BB01-DF3E-4298-95E8-25F05262E87DQ36465836-DFFE609F-03CA-4D82-B8C8-968C433BA260Q36468052-E420B380-7879-44B4-97B2-BCCC662CF14DQ36468107-47DCABBA-A4B7-4E33-A749-386E6451ED7BQ36880048-231BC2F3-5685-466C-9907-92E6118B5F40Q36946008-A3FFC6AF-BDDA-4293-B9CE-8E124EBAFE51Q37021182-CD9C5E60-EB70-4BC6-956F-F9E362B54B85Q37025619-65C5C820-9719-46DD-9FE7-BDA43C2B5CB7Q37366511-C39BBDF9-8E34-4498-B2FE-C0481A7E0A95Q37622884-C15EBAB3-2FE5-4739-8D15-4C472990E99CQ37679903-DADA2132-C5CE-4771-BE2A-E24A291DA944Q37766896-6BDC311B-7AFA-4747-A8BE-69600F664875Q37803635-80D4599E-196C-40AD-B644-3B3BA605EDE2Q37803637-4D2D4E08-A7AA-464B-8B72-F3E7D114CB58Q37938324-905C3E37-4E1D-49DC-AEEF-F7911BB14266Q38059807-20E27A81-55EB-41CB-A602-074E587293ECQ38641282-D2DE8415-5C58-486E-A80E-172965666570Q40942814-26B57003-538A-4749-96B1-9892302C64FAQ41463872-926FEA83-0396-4D44-987D-252A73BB21CCQ41463923-28D15444-9970-4A55-97AD-DBCAF5CD4F0A
P2860
Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Aminoglutethimide inhibits ext ...... l women with breast carcinoma.
@en
type
label
Aminoglutethimide inhibits ext ...... l women with breast carcinoma.
@en
prefLabel
Aminoglutethimide inhibits ext ...... l women with breast carcinoma.
@en
P2093
P356
P1476
Aminoglutethimide inhibits ext ...... l women with breast carcinoma.
@en
P2093
P304
P356
10.1210/JCEM-47-6-1257
P407
P577
1978-12-01T00:00:00Z